pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
Oncotice
Tice BCG
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$MRKMerck & Co., Inc.
0 catalysts
Marketed
Onyda XR
Onyda XR (clonidine hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
Tris Pharma Inc
0 catalysts
Phase 2
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
← prev
page 138 of 271
next →
131
Pain89
Neurology1
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
0 catalysts
Marketed
Opzelura
Opzelura (ruxolitinib phosphate)
Hidradenitis Suppurativa
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
$INCYINCYTE CORP
0 catalysts
Marketed
Orabloc
Orabloc ((articaine hydrochloride + epinephrine bitartrate))
Local Anesthetic Effect
Pierrel SpA
0 catalysts
Phase 2
Oral Psilocybin
psilocybin
Substance (Drug) Abuse
5-hydroxytryptamine receptor 2A
Revive Therapeutics Ltd
0 catalysts
Marketed
Oraqix
Oraqix ((lidocaine + prilocaine))
Local Anesthetic Effect
DENTSPLY Pharmaceutical
0 catalysts
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
0 catalysts
Phase 2
OriCAR-017
Refractory Multiple Myeloma
Oricell Therapeutics (Shanghai) Co Ltd
0 catalysts
Preclinical
Oximo
Genital Herpes
Oxymo Technologies Inc
0 catalysts
Marketed
Oxsoralen-Ultra
Methoxsalen Oceanside (methoxsalen)
Psoriasis
Bausch Health US LLC
0 catalysts
Preclinical
Oxy-133
Osteoporosis
Max Biopharma Inc
0 catalysts
Preclinical
Oxy-210
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Max Biopharma Inc
0 catalysts
Marketed
Oxybutynin Chloride Teva
Oxybutynin Chloride (oxybutynin chloride)
Dysuria
Teva Pharmaceuticals USA Inc
0 catalysts
pre_registration
Ozempic
Ozempic (semaglutide)
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Glucagon-like peptide 1 receptor
Novo Nordisk AS
0 catalysts
Phase 1
P-01
Pancreatic Cancer
Hangzhou Neoantigen Therapeutics Co Ltd
0 catalysts
Preclinical
P-1155
Chronic Obstructive Pulmonary Disease (COPD)
Parion Sciences Inc
0 catalysts
Phase 2
P-12
Burns
Penicillin-binding protein
NeoMatrix Therapeutics Inc
0 catalysts
Phase 2
P-4M01
Periodontal Disease
P4 Microbiome Inc
0 catalysts
Preclinical
P-8
Alzheimer's Disease
Cenna Biosciences Inc
0 catalysts
Preclinical
P-BCMACD19-ALLO1
Autoimmune Disorders
Poseida Therapeutics Inc
0 catalysts
Preclinical
P-MAPA
Schistosomiasis
Farmabrasilis
0 catalysts
Preclinical
P5P Analogues
Unspecified
$MCUJFMEDICURE INC
0 catalysts
Phase 1
PA-001
Coronavirus Disease 2019 (COVID-19)
PeptiAID Inc
0 catalysts
PADCEV
PADCEV (ENFORTUMAB VEDOTIN-EJFV)
Astellas Pharma Inc
0 catalysts
Phase 2
PALI-2108
Ulcerative Colitis
$PALIPALISADE BIO, INC.
0 catalysts
PALIPERIDONE
PALIPERIDONE (PALIPERIDONE)
Apotex Corp
0 catalysts
PALSONIFY
PALSONIFY (PALTUSOTINE HYDROCHLORIDE)
1 INDICATIONS AND USAGE PALSONIFY is indicated for the treatment of adults wi…
$CRNXCrinetics Pharmaceuticals, Inc.
0 catalysts
PANRETIN
PANRETIN (ALITRETINOIN)
Advanz Pharma Corp Ltd
0 catalysts